Orchard Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $743K | Sell |
79,208
-106,288
| -57% | -$997K | 0.82% | 29 |
|
|
2025
Q1 | $1.32M | Buy |
185,496
+173,339
| +1,426% | +$1.23M | 0.9% | 28 |
|
|
2024
Q4 | $142K | Buy |
12,157
+171
| +1% | +$1.99K | 0.06% | 54 |
|
|
2024
Q3 | $246K | Sell |
11,986
-158,020
| -93% | -$3.25M | 0.08% | 51 |
|
|
2024
Q2 | $3.8M | Sell |
170,006
-2,310
| -1% | -$51.7K | 1.15% | 32 |
|
|
2024
Q1 | $4.74M | Buy |
172,316
+2,310
| +1% | +$63.5K | 1.39% | 33 |
|
|
2023
Q4 | $5.18M | Buy |
170,006
+10,851
| +7% | +$331K | 1.62% | 32 |
|
|
2023
Q3 | $5.03M | Hold |
159,155
| – | – | 1.86% | 31 |
|
|
2023
Q2 | $6.49M | Buy |
+159,155
| New | +$6.49M | 2.18% | 28 |
|